
Effect of Octreotide on Gastrointestinal Motility in Children with Functional Gastrointestinal Symptoms
Author(s) -
Carlo Di Lorenzo,
Cristina Lucanto,
Alex F. C. Flores,
Shaheen Idries,
P E Hyman
Publication year - 1998
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/00005176-199811000-00002
Subject(s) - octreotide , medicine , motility , gastroenterology , somatostatin , migrating motor complex , antrum , constipation , endocrinology , small intestine , stomach , biology , genetics
The somatostatin analogue octreotide has been proposed as a possible therapeutic agent in patients with abnormal gastrointestinal motility. This study was conducted to study the effects of 0.5 microg/kg and 1.0 microg/kg subcutaneous octreotide on antroduodenal motility in children with chronic gastrointestinal disorders.